Evidence map›Paper›PMID 36673623›Full record

ArticleHealthcare (Basel, Switzerland)2023

Assessment of Knowledge, Perception, Experience and Phobia toward Corticosteroids Use among the General Public in the Era of COVID-19: A Multinational Study.

Muna Barakat, Mohamed Hassan Elnaem, Amani Al-Rawashdeh, Bayan Othman, Sarah Ibrahim, Doaa H Abdelaziz, Anas O Alshweiki, Zelal Kharaba, Diana Malaeb, Nabeel Kashan Syed and 8 more

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 11 countries.

Muna BarakatDepartment of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman 11931, Jordan.ORCID 0000-0002-7966-1172
Mohamed Hassan ElnaemSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia.ORCID 0000-0003-0873-6541
Amani Al-RawashdehFaculty of Pharmacy, Amman Arab University, Amman 11953, Jordan.
Bayan OthmanDepartment of Pharmaceutical Sciences and Pharmaceutics, Faculty of Pharmacy, Applied Science Private University, Amman 11931, Jordan.
Sarah IbrahimDepartment of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.
Doaa H AbdelazizPharmacy Practice and Clinical Pharmacy Department, Faculty of Pharmacy, Future University in Egypt, Cairo 11835, Egypt.
Anas O AlshweikiDepartment of Pharmaceutical Sciences and Pharmaceutics, Faculty of Pharmacy, Applied Science Private University, Amman 11931, Jordan.ORCID 0000-0002-0857-504X
Zelal KharabaDepartment of Clinical Pharmacy, College of Pharmacy, Al Ain University, Abu Dhabi 112612, United Arab Emirates.
Diana MalaebCollege of Pharmacy, Gulf Medical University, Ajman P.O. Box 4184, United Arab Emirates.
Nabeel Kashan SyedPharmacy Practice Research Unit, Department of Pharmacy Practice, College of Pharmacy, Jazan University, Gizan 45142, Saudi Arabia.
Abdulqadir J NashwanDepartment of Nursing Education & Practice Development, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha 3050, Qatar.ORCID 0000-0003-4845-4119
Mohammed Fathelrahman AdamFaculty of Pharmacy, University of Science and Technology, Omdurman 14411, Sudan.ORCID 0000-0001-6930-9004
Reem AlzayerClinical pharmacy Practice, Department of pharmacy, Mohammed Al-Mana College for Medical Sciences, Dammam 34222, Saudi Arabia.
Mohammad Saleh AlbarbandiDepartment of Neurosurgery, Ibn Al-Nafees Hospital, Damascus G8W4+MQW, Syria.
Rana K Abu-FarhaDepartment of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman 11931, Jordan.ORCID 0000-0001-8298-4071
Malik SallamDepartment of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.ORCID 0000-0002-0165-9670
Yasmeen BarakatDepartment of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman 11931, Jordan.
Noha O MansourClinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.ORCID 0000-0002-4448-994X
Applied Science Private University · JOUniversity of Jordan · JOAl Ain University · AEAmman Arab University · JODamascus Hospital · SYFuture University in Egypt · EGGulf Medical University · AEHamad General Hospital · QAJazan University · SAMansoura University · EGUniversiti Sains Malaysia · MYUniversity of Science and Technology Omdurman · SD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCorticosteroids play a significant role in managing the vast majority of inflammatory and immunologic conditions. To date, population-based studies on knowledge and attitudes concerning corticosteroids are scarce. This study aims to comprehensively assess knowledge, perception, experience and phobia toward corticosteroid use among the general population in the era of COVID-19.

methodsA cross-sectional self-administrated questionnaire was used to collect the data from 6 countries. Knowledge and corticophobia scores, descriptive statistics and logistic regression were computed.

resultsA total of 2354 participants were enrolled in this study; the majority were females (61.6%) with an average age of 30. Around 61.9% had been infected previously with COVID-19, and about one-third of the participants had experience with corticosteroid use. The mean knowledge score was relatively satisfactory (8.7 ± 4.5 out of 14), and Corticophobia ranked a high score in all countries. Age, female gender, and history of COVID-19 were positively correlated with developing corticophobia.

conclusionOur study highlights that the general knowledge about steroids was satisfactory. However, the phobia toward its use upon indication is high. Therefore, enhancing awareness and providing essential counseling regarding the rational use of corticosteroids may reduce corticophobia.

Indexed as

corticophobiacorticosteroidsCOVID-19knowledgeperception

Identifiers

PMID36673623
PMCPMC9859254
OpenAlexW4316465479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.